Characterisation of endoscopic improvements with risankizumab treatment in patients with moderately to severely active Crohn's disease

被引：0

作者：

Reinisch, W. ^{[1
]}

Colombel, J. F. ^{[2
]}

Ma, C. ^{[3
]}

Long, M. ^{[4
]}

Irving, P. M. ^{[5
]}

O'Brien, D. ^{[6
]}

Kligys, K. ^{[6
]}

Song, A. ^{[6
]}

Zhang, Y. ^{[6
]}

D'Haens, G. ^{[7
]}

机构：

[1] Med Univ Vienna, Dept Gastroenterol & Hepatol, Vienna, Austria

[2] Icahn Sch Med Mt Sinai, Dept Gastroenterol, New York, NY USA

[3] Univ Calgary, Div Gastroenterol & Hepatol, Calgary, AB, Canada

[4] Univ N Carolina, Div Gastroenterol & Hepatol, Ctr Gastrointestinal Biol & Dis, Chapel Hill, NC USA

[5] Guys & St Thomas NHS Fdn Trust, Dept Gastroenterol, London, England

[6] AbbVie Inc, Res & Dev, N Chicago, IL USA

[7] Univ Amsterdam, Dept Gastroenterol, Med Ctr, Amsterdam, Netherlands

来源：

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

P741

引用

页码：I1378 / I1379

页数：2